1967 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2000

Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine

Albrecht, M. A., Hughes, M. D., Liou, S. H., Katzenstein, D. A., Murphy, R., Balfour, H. H., Para, M. F., Valdez, H. & Hammer, S. M., Sep 20 2000, In : AIDS Research and Human Retroviruses. 16, 14, p. 1337-1344 8 p.

Research output: Contribution to journalArticle

5 Scopus citations

Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infection

Anderson, P. L., Noormohamed, S. E., Henry, K., Brundage, R. C., Balfour, H. H. & Fletcher, C. V., Jan 1 2000, In : Pharmacotherapy. 20, 8I, p. 917-922 6 p.

Research output: Contribution to journalArticle

20 Scopus citations
1999
13 Scopus citations
1998

A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS

Henry, K., Erice, A., Tierney, C., Balfour, H. H., Fischl, M. A., Kmack, A., Liou, S. H., Kenton, A., Hirsch, M. S., Phair, J., Martinez, A. & Kahn, J. O., Dec 1 1998, In : Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 19, 4, p. 339-349 11 p.

Research output: Contribution to journalArticle

59 Scopus citations

Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both

El-Sadr, W. M., Murphy, R. L., Yurik, T. M. C., Luskin-Hawk, R., Cheung, T. W., Balfour, H. H., Eng, R., Hooton, T. M., Kerkering, T. M., Schutz, M., Van Der Horst, C. D. & Hafner, R., Dec 24 1998, In : New England Journal of Medicine. 339, 26, p. 1889-1895 7 p.

Research output: Contribution to journalArticle

137 Scopus citations

Concentration-controlled zidovudine therapy

Fletcher, C. V., Acosta, E. P., Henry, K., Page, L. M., Gross, C. R., Kawle, S. P., Remmel, R. P., Erice, A. & Balfour, H. H., Sep 1 1998, In : Clinical pharmacology and therapeutics. 64, 3, p. 331-338 8 p.

Research output: Contribution to journalArticle

81 Scopus citations

Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis

Erice, A., Borrell, N., Li, W., Miller, W. J. & Balfour, H. H., Jan 1 1998, In : Journal of Infectious Diseases. 178, 2, p. 531-534 4 p.

Research output: Contribution to journalArticle

75 Scopus citations

Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients

Gaudreau, A., Hill, E., Balfour, H. H., Erice, A. & Boivin, G., Jan 1 1998, In : Journal of Infectious Diseases. 178, 2, p. 297-303 7 p.

Research output: Contribution to journalArticle

146 Scopus citations

Varicella: Una malattia curabile che vale la pena curare

Balfour, H. H., Dec 1 1998, In : Rivista Italiana di Pediatria. 24, 6, p. XIX-XX

Research output: Contribution to journalArticle

1 Scopus citations
1997

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less

Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J. E., Balfour, H. H., Deyton, L. R., Chodakewitz, J. A., Fischl, M. A., Phair, J. P., Spreen, W., Pedneault, L., Nguyen, B. Y. & Cook, J. C., Sep 11 1997, In : New England Journal of Medicine. 337, 11, p. 725-733 9 p.

Research output: Contribution to journalArticle

2283 Scopus citations

Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients

Erice, A., Gil-Roda, C., Pérez, J. L., Balfour, H. H., Sannerud, K. J., Hanson, M. N., Boivin, G. & Chou, S., Jan 1 1997, In : Journal of Infectious Diseases. 175, 5, p. 1087-1092 6 p.

Research output: Contribution to journalArticle

129 Scopus citations

Methodologie des essais cliniques dans le zona

Translated title of the contribution: Methodology of clinical trials in herpes zosterBalfour, H. H., Dec 1 1997, In : Annales de Dermatologie et de Venereologie. 124, SUPPL. 2, p. 2S 18-2S 20

Research output: Contribution to journalArticle

Mutations in cytomegalovirus ul97 and dna polymerase: structural models of the effects on drug resistance

Erice, A., Grys, T., Balfour, H., Bell, J. & Bell, E., Dec 1 1997, In : FASEB Journal. 11, 9, p. A1438

Research output: Contribution to journalArticle

Pharmacokinetics and safety of concentration-controlled oral zidovudine therapy

Acosta, E. P., Henry, K., Page, L. M., Erice, A., Balfour, H. H. & Fletcher, C. V., May 1 1997, In : Pharmacotherapy. 17, 3, p. 424-430 7 p.

Research output: Contribution to journalArticle

6 Scopus citations

Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDS

Fletcher, C. V., Goodroad, B. K., Cummins, L. M., Henry, K., Balfour, H. H. & Rhame, F. S., Jul 1997, In : Antimicrobial agents and chemotherapy. 41, 7, p. 1571-1574 4 p.

Research output: Contribution to journalArticle

Open Access
12 Scopus citations
11 Scopus citations
1996

Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS

Balfour, H. H., Fletcher, C. V., Erice, A., Henry, W. K., Acosta, E. P., Smith, S. A., Holm, M. A., Boivin, G., Shepp, D. H., Crumpacker, C. S., Eaton, C. A. & Martin-Munley, S. S., Dec 1 1996, In : Antimicrobial agents and chemotherapy. 40, 12, p. 2721-2726 6 p.

Research output: Contribution to journalArticle

22 Scopus citations

Prevention of cytomegalovirus disease

Balfour, H. H., Oct 1 1996, In : International Journal of Antimicrobial Agents. 7, 4, p. 283-285 3 p.

Research output: Contribution to journalArticle

3 Scopus citations

Quantitative image analysis of HIV-1 infection in lymphoid tissue

Haase, A. T., Henry, K., Zupancic, M., Sedgewick, G., Faust, R. A., Melroe, H., Cavert, W., Gebhard, K., Staskus, K., Zhang, Z. Q., Dailey, P. J., Balfour, H. H., Erice, A. & Perelson, A. S., Nov 8 1996, In : Science. 274, 5289, p. 985-989 5 p.

Research output: Contribution to journalArticle

482 Scopus citations

Variability in zidovudine serum concentrations

Fletcher, C. V. & Balfour, H. H., Nov 1 1996, In : Pharmacotherapy. 16, 6 I, p. 1154-1158 5 p.

Research output: Contribution to journalArticle

19 Scopus citations
1995

A comparison of immediate with deferred zidovudine therapy for asymptomatic hiv-infected adults with cd4 cell counts of 500 or more per cubic millimeter

Volberding, P. A., Lagakos, S. W., Grimes, J. M., Stein, D. S., Rooney, J., Meng, T. C., Fischl, M. A., Collier, A. C., Phair, J. P., Hirsch, M. S., Hardy, W. D., Balfour, H. H. & Reichman, R. C., Aug 17 1995, In : New England Journal of Medicine. 333, 7, p. 401-407 7 p.

Research output: Contribution to journalArticle

109 Scopus citations

Acyclovir for childoon chickenpox: No reason not to treat

Balfour, H. H., Jan 14 1995, In : British Medical Journal. 310, 6972, p. 109-110 2 p.

Research output: Contribution to journalArticle

7 Scopus citations

Congenital cytomegalovirus infection as a result of nonprimary cytomegalovirus disease in a mother with acquired immunodeficiency syndrome

Schwebke, K., Henry, K., Balfour, H. H., Olson, D., Crane, R. T. & Jordan, M. C., Feb 1995, In : The Journal of pediatrics. 126, 2, p. 293-295 3 p.

Research output: Contribution to journalArticle

19 Scopus citations

Strategies for control of zidovudine concentrations in serum

Noormohamed, S. E., Henry, W. K., Rhame, F. S., Balfour, H. H. & Fletcher, C. V., Jan 1 1995, In : Antimicrobial agents and chemotherapy. 39, 12, p. 2792-2797 6 p.

Research output: Contribution to journalArticle

10 Scopus citations

The Effect of Cimetidine and Ranitidine Administration With Zidovudine

Fletcher, C. V., Henry, W. K., Noormohamed, S. E., Rhame, F. S. & Balfour, H. H., Jan 1 1995, In : Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 15, 6, p. 701-708 8 p.

Research output: Contribution to journalArticle

20 Scopus citations
1994

A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation

Dunn, D. L., Gillingham, K. J., Kramer, M. A., Schmidt, W. J., Erice, A., Balfour, H. H., Gores, P. F., Gruessner, R. W. G., Matas, A. J., Payne, W. D., Sutherland, D. E. R. & Najarian, J. S., Mar 1994, In : Transplantation. 57, 6, p. 876-884 9 p.

Research output: Contribution to journalArticle

70 Scopus citations

Clinical aspects of chickenpox and herpes zoster

Balfour, H. H., Jan 1 1994, In : Journal of International Medical Research. 22, SUPPL. 1, p. 3A-13A

Research output: Contribution to journalArticle

5 Scopus citations

Introduction

Balfour, H. H., Jan 1 1994, In : Pediatric Infectious Disease Journal. 13, 5, 1 p.

Research output: Contribution to journalArticle

Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections

Balfour, H. H., Benson, C., Braun, J., Cassens, B., Erice, A., Friedman-Kien, A., Klein, T., Polsky, B. & Safrin, S., Mar 1994, In : Journal of Acquired Immune Deficiency Syndromes. 7, 3, p. 254-260 7 p.

Research output: Contribution to journalArticle

133 Scopus citations

Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells

Peterson, P. K., Gekker, G., Hu, S., Anderson, W. R., Kravitz, F., Portoghese, P. S., Balfour, H. H. & Chao, C. C., Mar 1994, In : Journal of Neuroimmunology. 50, 2, p. 167-175 9 p.

Research output: Contribution to journalArticle

97 Scopus citations

Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with aids

Boivin, G., Edelman, C. K., Pedneault, L., Talarico, C. L., Biron, K. K. & Balfour, H. H., Jul 1994, In : Journal of Infectious Diseases. 170, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

90 Scopus citations

Prevalence of oral lesions in symptomatic and asymptomatic HIV patients.

Little, J. W., Melnick, S. L., Rhame, F. S., Balfour, H. H., Decher, L., Rhodus, N. L., Merry, J. W., Walker, P. O., Miller, C. E. & Volberding, P., Jan 1 1994, In : General Dentistry. 42, 5, p. 446-450 5 p.

Research output: Contribution to journalArticle

3 Scopus citations

Recurrent ocular herpes simplex infection

Parikh, H. S. & Balfour, H. H., Feb 1994, In : Pediatric Infectious Disease Journal. 13, 2, 1 p.

Research output: Contribution to journalArticle

1 Scopus citations

Resistance of human immunodeficiency virus type 1 to antiretroviral agents: A

Erice, A. & Balfour, H. H., Feb 1994, In : Clinical Infectious Diseases. 18, 2, p. 149-156 8 p.

Research output: Contribution to journalArticle

43 Scopus citations

Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1

Aids Clinical Trials Group Virology Laboratories, Apr 1994, In : Journal of Infectious Diseases. 169, 4, p. 713-721 9 p.

Research output: Contribution to journalArticle

31 Scopus citations

The Duration of Zidovudine Benefit in Persons With Asymptomatic HIV Infection: Prolonged Evaluation of Protocol 019 of the AIDS Clinical Trials Group

Volberding, P. A., Lagakos, S. W., Grimes, J. M., Stein, D. S., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., Phair, J. P., Mitsuyasu, R. T., Fischl, M. A. & Soeiro, R., Aug 10 1994, In : JAMA: The Journal of the American Medical Association. 272, 6, p. 437-442 6 p.

Research output: Contribution to journalArticle

121 Scopus citations

Use of semiquantitative human immunodeficiency virus type 1 culture to guide therapy in a premature infant

Toltzis, P., Marx, C. M., Balfour, H. H. & Jackson, B., Jan 1 1994, In : American Journal of Clinical Pathology. 101, 6, p. 753-755 3 p.

Research output: Contribution to journalArticle

1993

Anti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral protein

Erice, A., Balfour, H. H., Myers, D. E., Leske, V. L., Sannerud, K. J., Kuebelbeck, V., Irvin, J. D. & Uckun, F. M., Jan 1 1993, In : Antimicrobial agents and chemotherapy. 37, 4, p. 835-838 4 p.

Research output: Contribution to journalArticle

39 Scopus citations

Current management of varicella zoster virus infections

Balfour, H. H., 1993, In : Journal of Medical Virology. 41, 1 S, p. 74-81 8 p.

Research output: Contribution to journalArticle

19 Scopus citations

Cytomegalovirus infections and liver transplantation: An overview

Balfour, H. H. & Heussner, R. C., Jan 1 1993, In : Transplantation proceedings. 25, 2, p. 2012-2013 2 p.

Research output: Contribution to journalArticle

4 Scopus citations

Effect of oral acyclovir on pain resolution in herpes zoster: A reanalysis

Huff, J. C., Drucker, J. L., Clemmer, A., Laskin, O. L., Connor, J. D., Bryson, Y. J. & Balfour, H. H., 1993, In : Journal of Medical Virology. 41, 1 S, p. 93-96 4 p.

Research output: Contribution to journalArticle

79 Scopus citations

Enhancement of HIV-1 replication by opiates and cocaine: The cytokine connection

Peterson, P. K., Gekker, G., Schut, R., Hu, S., Balfour, H. H. & Chao, C. C., Jan 1 1993, In : Advances in experimental medicine and biology. 335, p. 181-188 8 p.

Research output: Contribution to journalArticle

68 Scopus citations

Ganciclovir Susceptibilities of Cytomegalovirus (CMV) Isolates from Solid Organ Transplant Recipients with CMV Viremia after Antiviral Prophylaxis

Balfour, H. H., Boivin, G., Erice, A., Crane, D. D. & Dunn, D., Aug 1993, In : Journal of Infectious Diseases. 168, 2, p. 332-335 4 p.

Research output: Contribution to journalArticle

63 Scopus citations

Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1

Erice, A., Mayers, D. L., Strike, D. G., Sannerud, K. J., McCutchan, F. E., Henry, K. & Balfour, H. H., Apr 22 1993, In : New England Journal of Medicine. 328, 16, p. 1163-1165 3 p.

Research output: Contribution to journalArticle

213 Scopus citations

Transmission of zidovudine-resistant AIDS virus report

Balfour, H. H., 1993, In : Biomedicine and Pharmacotherapy. 47, 9, 1 p.

Research output: Contribution to journalArticle

VARICELLA: COME E QUANDO IMPOSTARE IL TRATTAMENTO ANTIVIRALE

Translated title of the contribution: Chickenpox: How and when starting the antiviral treatmentBalfour, H. H., Jan 1 1993, In : Minerva Pediatrica. 45, 3, p. 107-112 6 p.

Research output: Contribution to journalArticle

1 Scopus citations
1992

Acyclovir therapy is indicated for varicella in individuals with normal immunity

Balfour, H. H. . & Wood, M. J., Mar 1992, In : Reviews in Medical Virology. 2, 1, p. 1-7 7 p.

Research output: Contribution to journalArticle

5 Scopus citations

Acyclovir treatment of varicella in otherwise healthy adolescents

Balfour, H. H., Rotbart, H. A., Feldman, S., Dunkle, L. M., Feder, H. M., Prober, C. G., Hayden, G. F., Steinberg, S., Whitley, R. J., Goldberg, L. & McGuirt, P. V., Apr 1992, In : The Journal of pediatrics. 120, 4 PART 1, p. 627-633 7 p.

Research output: Contribution to journalArticle

131 Scopus citations

Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures

Peterson, P. K., Gekker, G., Chao, C. C., Schut, R., Verhoef, J., Edelman, C. K., Erice, A. & Balfour, H. H., Jan 1 1992, In : Journal of Immunology. 149, 2, p. 676-680 5 p.

Research output: Contribution to journalArticle

49 Scopus citations

Comparative Pharmacokinetics of Zidovudine in Healthy Volunteers and in Patients With AIDS With and Without Hepatic Disease

Fletcher, C. V., Beatty, C. C., Simpson, M. & Balfour, H. H., Jan 1 1992, In : Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 12, 6, p. 429-434 6 p.

Research output: Contribution to journalArticle

24 Scopus citations